Join

Compare · HJLI vs RMD

HJLI vs RMD

Side-by-side comparison of Hancock Jaffe Laboratories, Inc. (HJLI) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both HJLI and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • RMD is the larger of the two at $27.05B, about 297.6x HJLI ($90.9M).
  • RMD has hit the wire 7 times in the past 4 weeks while HJLI has been quiet.
  • RMD has more recent analyst coverage (25 ratings vs 0 for HJLI).
MetricHJLIRMD
Company
Hancock Jaffe Laboratories, Inc.
ResMed Inc.
Price
$10.42-1.33%
$186.48+1.93%
Market cap
$90.9M
$27.05B
1M return
-
-10.85%
1Y return
-
-24.50%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
2018
News (4w)
0
7
Recent ratings
0
25
HJLI

Hancock Jaffe Laboratories, Inc.

Hancock Jaffe Laboratories, Inc., a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA.

RMD

ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Latest HJLI

Latest RMD